Literature DB >> 1664714

Quantitation of soluble CD27, a T-cell activation antigen, and soluble interleukin-2 receptor in serum from patients with psoriasis.

M A de Rie1, F Hamerlinck, R Q Hintzen, J D Bos, R A van Lier.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 1664714     DOI： 10.1007/bf00371929

Source DB:  PubMed          Journal:  Arch Dermatol Res        ISSN： 0340-3696            Impact factor:   3.017


× No keyword cloud information.
  10 in total

1.  A soluble form of the human T cell differentiation antigen CD27 is released after triggering of the TCR/CD3 complex.

Authors:  R Q Hintzen; R de Jong; C E Hack; M Chamuleau; E F de Vries; I J ten Berge; J Borst; R A van Lier
Journal:  J Immunol       Date:  1991-07-01       Impact factor: 5.422

2.  Tissue distribution and biochemical and functional properties of Tp55 (CD27), a novel T cell differentiation antigen.

Authors:  R A van Lier; J Borst; T M Vroom; H Klein; P Van Mourik; W P Zeijlemaker; C J Melief
Journal:  J Immunol       Date:  1987-09-01       Impact factor: 5.422

3.  Interleukin 2, soluble interleukin 2 receptor, and interferon-gamma in the suction blister fluids from psoriatic skin.

Authors:  H Takematsu; H Tagami
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

Review 4.  The pathomechanisms of psoriasis; the skin immune system and cyclosporin.

Authors:  J D Bos
Journal:  Br J Dermatol       Date:  1988-02       Impact factor: 9.302

Review 5.  The soluble interleukin-2 receptor: biology, function, and clinical application.

Authors:  L A Rubin; D L Nelson
Journal:  Ann Intern Med       Date:  1990-10-15       Impact factor: 25.391

6.  Elevated levels of soluble CD8 antigen in sera of patients with psoriasis--a possible sign of suppressor/cytotoxic T-cell activation.

Authors:  A Kapp
Journal:  Arch Dermatol Res       Date:  1990       Impact factor: 3.017

7.  Elevated levels of interleukin 2 receptor in sera of patients with atopic dermatitis and psoriasis.

Authors:  A Kapp; A Piskorski; E Schöpf
Journal:  Br J Dermatol       Date:  1988-12       Impact factor: 9.302

8.  Severe psoriasis--oral therapy with a new retinoid.

Authors:  T Fredriksson; U Pettersson
Journal:  Dermatologica       Date:  1978

9.  Interleukin-1 release from peripheral blood monocytes and soluble interleukin-2 and CD8 receptors in serum from patients with atopic dermatitis.

Authors:  K Thestrup-Pedersen; C S Larsen; M Kristensen; C Zachariae
Journal:  Acta Derm Venereol       Date:  1990       Impact factor: 4.437

10.  Serum-soluble interleukin 2 receptor in psoriasis. Failure to reflect clinical improvement.

Authors:  D Kemmett; J A Symons; G B Colver; G W Duff
Journal:  Acta Derm Venereol       Date:  1990       Impact factor: 4.437
  10 in total
  1 in total

1.  Reappraisal of in situ immunophenotypic analysis of psoriasis skin: interaction of activated HLA-DR+ immunocompetent cells and endothelial cells is a major feature of psoriatic lesions.

Authors:  O J de Boer; C M van der Loos; F Hamerlinck; J D Bos; P K Das
Journal:  Arch Dermatol Res       Date:  1994       Impact factor: 3.017
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.